Gynecologic Oncology Faculty

Dr. Whitney Graybill joined MUSC Women's Care as a gynecologist oncologist in 2010. Dr. Graybill graduated undergrad from Vanderbilt University. She graduated medical school from Quillen College of Medicine in Tennessee and residency at the University of Alabama. Dr. Graybill completed her fellowship in gynecologic oncology at the University of Texas MD Anderson Cancer Center. Her interests include minimally invasive robotic surgery, clinical trials, and translational ovarian cancer research.

Dr. Justin Harold is a gynecologic oncologist at Hollings Cancer Center. Born and raised in rural South Carolina, he went to Clemson University and then University of South Carolina for medical school. He completed residency at Medical College of Wisconsin and then fellowship training at Yale. His research interests in fellowship included testing new targeted therapies for uterine leiomyosarcoma and uterine serous carcinoma. Dr. Harold's specialties include radical surgery for ovarian cancer, minimally invasive surgery (robotic, laparoscopic, and vaginal), and surgery for vulvar cancer.

Dr. David Mysona is a gynecologic oncologist at Hollings Cancer Center. He takes care of women with cancers of the ovaries, uterus, cervix, vagina, and vulva. He performs open, robotic, vaginal, and laparoscopic surgeries. He also specializes in chemotherapy, hyperthermic intraperitoneal chemotherapy, and immunotherapy.

Dr. Mysona went to college at the University of South Carolina, where he studied biomedical engineering. He earned his medical degree from the Medical College of Georgia and completed his residency in obstetrics and gynecology at the University of North Carolina. He returned to the Medical College of Georgia for his gynecologic oncology fellowship. Dr. Mysona's research focuses on how to better match therapies to each patient.

Dr. Brian Orr is a gynecologic oncologist at Hollings Cancer Center and associate professor at Medical University of South Carolina. He completed residency at the University of South Florida and fellowship training at the University of Pittsburgh. As faculty at University of Pittsburgh, he completed a master's degree in Clinical and Translational Science.

In addition to clinical activities of minimally invasive surgery, chemotherapy, and HIPEC for gynecologic cancer patients, he is active in clinical research. Dr. Orr's research interests are in translational clinical trial development for ovarian, uterine, cervical, and vulvar cancers. His expertise is in immunotherapy and targeted therapies.